[{"id":"9edba769-a2fe-4a3c-b3fd-9b103fea814d","acronym":"WEE1","url":"https://clinicaltrials.gov/study/NCT04768868","created_at":"2021-02-24T13:59:57.527Z","updated_at":"2024-07-02T16:35:54.795Z","phase":"Phase 1","brief_title":"The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT04768868 - WEE1","lead_sponsor":"Impact Therapeutics, Inc.","biomarkers":" PD-L1 • MSI • NTRK","pipe":" | ","alterations":" MSI-H/dMMR • NTRK fusion","tags":["PD-L1 • MSI • NTRK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR • NTRK fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IMP7068"],"overall_status":"Recruiting","enrollment":" Enrollment 350","initiation":"Initiation: 02/25/2021","start_date":" 02/25/2021","primary_txt":" Primary completion: 04/30/2023","primary_completion_date":" 04/30/2023","study_txt":" Completion: 08/30/2023","study_completion_date":" 08/30/2023","last_update_posted":"2023-02-24"}]